Psyence Biomedical (PBM) EBIAT (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly EBIAT of -$753254.0 in Q3 2025, down 632.44% quarter-over-quarter from $141473.0 in Q3 2024, and down 632.44% on a YoY basis from $141473.0 in Q3 2024.
Psyence Biomedical (PBM) EBIAT (2023 - 2025) Analysis & Trends
Psyence Biomedical's EBIAT history runs 3 years deep, the most recent figure standing at -$753254.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 727.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -753,254.00 |
| Sep 30, 2024 | 141,473.00 |
| Mar 31, 2023 | -3.21 Mn |